ALB and brain infarction: A secondary analysis showed that higher dosages of albumin were associated with a lower incidence of vasospasm, DCI, and cerebral infarction at 90 days, in a dose‐dependent fashion.97 Further studies are currently underway to further evaluate the role of albumin in the management of aSAH and cerebral vasospasm.